标题
Management of Refractory OAB in the Non-Neurogenic Patient
作者
关键词
OAB, Refractory, Treatment
出版物
Current Urology Reports
Volume 15, Issue 9, Pages -
出版商
Springer Nature
发表日期
2014-07-11
DOI
10.1007/s11934-014-0438-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
- (2013) Jai H. Seth et al. BJU INTERNATIONAL
- Defining response and non-response to treatment in patients with overactive bladder: a systematic review
- (2013) Howard B. Goldman et al. CURRENT MEDICAL RESEARCH AND OPINION
- Global Prevalence and Economic Burden of Urgency Urinary Incontinence: A Systematic Review
- (2013) Ian Milsom et al. EUROPEAN UROLOGY
- The medical management of refractory Overactive Bladder
- (2013) Dudley Robinson et al. MATURITAS
- Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics
- (2012) Kang Jun Cho et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity
- (2012) Seong Jin Jeong et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
- (2012) E. Ann Gormley et al. JOURNAL OF UROLOGY
- Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: A systematic review and meta-analysis
- (2012) C. Burton et al. NEUROUROLOGY AND URODYNAMICS
- Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome?
- (2012) Marc Tellenbach et al. WORLD JOURNAL OF UROLOGY
- Cost-effectiveness analysis of anti-muscarinic agents for the treatment of overactive bladder
- (2012) Edward P. Armstrong et al. JOURNAL OF MEDICAL ECONOMICS
- Contemporary Management of Lower Urinary Tract Disease With Botulinum Toxin A: A Systematic Review of Botox (OnabotulinumtoxinA) and Dysport (AbobotulinumtoxinA)
- (2011) Altaf Mangera et al. EUROPEAN UROLOGY
- Repeated Botulinum Toxin Type A Injections for Refractory Overactive Bladder: Medium-Term Outcomes, Safety Profile, and Discontinuation Rates
- (2011) Christopher Dowson et al. EUROPEAN UROLOGY
- Botulinum toxin A submucosal injection for refractory non-neurogenic overactive bladder: Early outcomes
- (2011) Kikuo Okamura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: Lack of anticholinergic efficacy versus intolerability
- (2011) Iryna Makovey et al. NEUROUROLOGY AND URODYNAMICS
- Gabapentin: A novel drug as add-on therapy in cases of refractory overactive bladder in children
- (2011) M.S. Ansari et al. Journal of Pediatric Urology
- Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial
- (2010) Roger Dmochowski et al. JOURNAL OF UROLOGY
- Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial
- (2010) Kenneth M. Peters et al. JOURNAL OF UROLOGY
- Augmentation Enterocystoplasty in Overactive Bladder: Is There Still a Role?
- (2010) Polina Reyblat et al. Current Urology Reports
- A candidate serum biomarker for bladder pain syndrome/interstitial cystitis
- (2009) Daniel E. Rubio-Diaz et al. ANALYST
- Double Anticholinergic Therapy for Refractory Overactive Bladder
- (2009) Stéphane Bolduc et al. JOURNAL OF UROLOGY
- Triple therapy in refractory detrusor overactivity: a preliminary study
- (2009) Ricardo Natalin et al. WORLD JOURNAL OF UROLOGY
- Validation of a sham for percutaneous tibial nerve stimulation (PTNS)
- (2008) Kenneth Peters et al. NEUROUROLOGY AND URODYNAMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started